Marker Therapeutics Inc (MRKR)

[microcapbiotech]

Howdy, As I stated here before, I'm not a doctor/scientist, but when I read the following:

"Group 2 will comprise 40 active disease patients in a single arm, with primary endpoints of complete remission and duration of complete remission."

I read that to mean, if you Don't get "complete remission", you failed the primary endpoint. There may be something I'm not aware of but I don't see the 30% or 20% you refer to.

I've read trial results of 40/50/60% partial response, or tumors have shrunk by 30/40/50%, or the disease was stabilized and the patient lived on for X amount of months/years … but it seems like None of anything like that would be any good if the end result has to be "complete remission".

If there's something I'm missing here, let me know because the more I learn about this the better off I am. Just because I invest in bio's, don't mean I understand everything that's going on.